Product Information
CYPROHEPTADINE 2 MG/5 ML SYRUP is a generic product labeled by Chartwell RX LLC, priced at $0.0419 per ML under NDC 62135094947. Its NADAC has been published 204 times since Nov 9, 2022.
FDA first approved this application on Jul 13, 2017. Its Orange Book therapeutic-equivalence code is AA.
Strength
2 mg/5mL
Manufacturer
Chartwell RX LLCNDC
62135094947
Classification
Generic
Dosage Form
SYRUP
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CYPROHEPTADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203191FDA Approved
7/13/2017
TE Code
AA
On Market Since
7/13/2017
Price Statistics
The NADAC for CYPROHEPTADINE 2 MG/5 ML SYRUP has been published 204 times since Nov 9, 2022, and over the history we have for it it has declined 28.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0419 per ML |
|---|---|
| All-time high | $0.0587 (Nov 16, 2022) |
| All-time low | $0.0377 (Jan 22, 2025) |
| 52-week high | $0.0423 |
| 52-week low | $0.0404 |
| Median price | $0.0423 |
| Average price | $0.0444 |
| Largest weekly change | +19.8% (Nov 22, 2023) |
| Weeks tracked | 204 |
| Tracking since | Nov 9, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CYPROHEPTADINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CYPROHEPTADINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CYPROHEPTADINE 2 MG/5 ML SYRUP?
The current National Average Drug Acquisition Cost (NADAC) for CYPROHEPTADINE 2 MG/5 ML SYRUP, manufactured by Chartwell RX LLC, is $0.0419 per ML (NDC 62135094947), effective Sep 30, 2026.
How has the price of CYPROHEPTADINE 2 MG/5 ML SYRUP changed over time?
Over the history we have for it, the NADAC for CYPROHEPTADINE 2 MG/5 ML SYRUP has declined 28.7%. It has been tracked across 204 weekly CMS publications since Nov 9, 2022.
What are the highest and lowest recorded NADAC prices for CYPROHEPTADINE 2 MG/5 ML SYRUP?
Since Nov 9, 2022, the NADAC for CYPROHEPTADINE 2 MG/5 ML SYRUP has ranged from a low of $0.0377 (Jan 22, 2025) to a high of $0.0587 (Nov 16, 2022), with a median of $0.0423 per ML.
Are there cheaper alternatives to CYPROHEPTADINE 2 MG/5 ML SYRUP?
No other NADAC-published product currently shares the active ingredient and strength of CYPROHEPTADINE 2 MG/5 ML SYRUP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CYPROHEPTADINE 2 MG/5 ML SYRUP?
CYPROHEPTADINE 2 MG/5 ML SYRUP (NDC 62135094947) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.